2 Einträge gefunden

1. A novel HRAS substitution (c.266C>G; p.S89C) resulting in decreased downstream signaling suggests a new dimension of RAS pathway dysregulation in human development.

   1. Gripp, Karen W
   2. Bifeld, Eugenia
   3. Stabley, Deborah L
   4. Hopkins, Elizabeth
   5. Meien, Stefanie
   6. Vinette, Kathy
   7. Sol-Church, Katia

   2012 - Forschungsinformationssystem des UKE
2. Oncogenic HRAS mutations cause prolonged PI3K signaling in response to epidermal growth factor in fibroblasts of patients with Costello syndrome.

   1. Rosenberger, Georg
   2. Meien, Stefanie
   3. Kutsche, Kerstin

   2009 - Forschungsinformationssystem des UKE